Viral nucleotide changes in asymptomatic hepatitis B carriers undergoing interferon treatment

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 2, 1996, Pages 199-202

  How, W ^a   Ng, W C ^a   Tan, M F ^a   Seet, B L ^a   Guan, R ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PREDNISOLONE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; VIRUS HEPATITIS;

EID: 0029918321     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.718898000.x     Document Type: Article

References (16)

1. Gunther S, Meisel H, Reip A, Miska S, Kruger DH, Will H. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology 1992; 187: 271-9.
2. Takeda K, Akahane Y, Suzuki H, et al. Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy. Hepatology 1990; 12: 1284-9.
3. Kaneko S, Feinstone SM, Miller RH. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol 1989; 27: 1930-3.
4. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; ii: 588-91.
5. Chuang W-L, Omata M, Ehata T, et al. Precore mutations and core clustering mutations in chronic hepatitis B virus infection. Gastroenterology 1993; 104: 263-71.
6. Ng WC, Guan R, Tan MF, et al. HCV genotypes in Singapore and Indonesia. Viral Hepatitis 1995; 2: 203-9.
7. Kobayashi M, Foike K. Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene 1984; 30: 227-32.
8. Fujiyama A, Miyanohara A, Nozaki C, et al. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res 1983; 11: 4601-8.
9. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishikoka K. The complete nucleotide sequences of the cloned hepatitis B virus DNA: subtype adr and adw. Nuclei Acids Res 1983; 11: 1747-57.
10. Galibert F, Mandart E, Fitoussi F, Tillais P, Charnay P. Nucleotide sequences of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979; 281: 646-50.
11. Pasek M, Goto T, Gilbert W, et al. Hepatitis B virus genes and their expression in E. coli. Nature 1979; 282: 575-9.
12. Tine F, Liberati A, Craxi A, Almasio P, Pagliaro L. Interferon treatment in patients with chronic hepatitis B: a meta-analysis of the published literature. J Hepatol 1993; 18: 154-62.
13. Lok ASF, Akarca US, Greene S. Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis e antigen clearance. Hepatology 1995; 21: 19-24.
14. Takayanagi M, Kakumu S, Ishikawa T, Higashi Y, Yoshioka K, Wakita T. Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection. Virology 1993; 196: 138-45.
15. Hasegawa K, Huang J, Rogers S, Blum H, Liang T. Enhanced replication of a Hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 1994; 68: 1651-9.
16. Kamogawa Y, Yamauchi K, Obata H, Chisaka O, Matsubara K. Hepatitis B virus-DNA transfected myeloma cell-specific cytotoxic T cells in chronic hepatitis B patients. Virology 1992; 191: 321-6.